ReviewFrontiers in pharmacology2020

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Inés Valencia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.